Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01897545 · ClinicalTrials.gov registry record · Phase 2

Combined Treatment of Arterial Hypertension and Atrial Fibrillation

A Phase 2 study of Atrial Fibrillation and Arterial Hypertension, sponsored by Meshalkin Research Institute of Pathology of Circulation.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
3
Study locations

NCT01897545 is a Phase 2 study of Atrial Fibrillation and Arterial Hypertension that has completed, run by Meshalkin Research Institute of Pathology of Circulation. The registered enrollment target is 60 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01897545, a Phase 2 study of Atrial Fibrillation and Arterial Hypertension, has completed, sponsored by Meshalkin Research Institute of Pathology of Circulation.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is the comparative evaluation of systolic blood pressure (SBP) lowering, atrial fibrillation (AF) recurrence and clinical data in patients with paroxysmal/persistent AF and resistant/non-resistant hypertension, undergoing AF ablation alone or combined with percutaneous renal denervation.

Conditions Studied

Atrial Fibrillation Arterial Hypertension

Interventions

  • PROCEDURE Circumferential PV isolation
  • PROCEDURE PV isolation+renal denervation

Study Locations (3)

Other

  • Athens Euroclinic - Athens
  • State Research Institute of Circulation Pathology - Novosibirsk

New York

  • The Valley Health System - New York

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2012-04
Est. Completion 2013-06
Phase Phase 2

Sponsor

Meshalkin Research Institute of Pathology of Circulation

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01897545

The ClinicalTrials.gov registry entry for NCT01897545 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Meshalkin Research Institute of Pathology of Circulation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Circumferential PV isolation is the first listed.

NCT01897545 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, New York.

Frequently Asked Questions

What is clinical trial NCT01897545 about?

NCT01897545 is a clinical study titled "Combined Treatment of Arterial Hypertension and Atrial Fibrillation". The purpose of this study is the comparative evaluation of systolic blood pressure (SBP) lowering, atrial fibrillation (AF) recurrence and clinical data in patients with paroxysmal/persistent AF and resistant/non-resistant hypertension, undergoing AF ablation alone or combined with percutaneous rena...

What is the current status of trial NCT01897545?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2012-04. Estimated completion is 2013-06.

What conditions does trial NCT01897545 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Arterial Hypertension.

What interventions are being tested in trial NCT01897545?

The interventions under investigation include: Circumferential PV isolation (PROCEDURE), PV isolation+renal denervation (PROCEDURE).

Who is sponsoring clinical trial NCT01897545?

This trial is sponsored by Meshalkin Research Institute of Pathology of Circulation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01897545 being conducted?

This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Arterial Hypertension

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.